FDA recall Z-1286-2023

Randox Laboratories · Class II · device

Product

CRP Immunoturbidimetric reagent. Intended for the quantitative in vitro determination of CRP concentration in serum Catalogue number: CP3826

Reason for recall

The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range

Distribution

PA, OH, WV

Key facts

Status
Ongoing
Initiation date
2023-02-01
Report date
2023-04-05
Voluntary/Mandated
Voluntary: Firm initiated
Location
Kearneysville, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1286-2023